Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine in Children With Relapsed ALL or AML
NCT00006462Phase 2Completed
- Sponsor
- Children's Oncology Group
- Start
- Apr 2001
- Primary completion
- Aug 2003
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of gemcitabine in acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), sponsored by Children's Oncology Group. Started Apr 2001; status: completed.
02
Drugs
gemcitabine
03
Conditions
acute lymphoblastic leukemia (ALL)acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00006462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006462.